Efficacy of a nasal vaccine containing recombinant hepatitis B surface and core antigens in healthy subjects
Phase of Trial: Phase I
Latest Information Update: 05 Nov 2010
At a glance
- Drugs ABX 203 (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacodynamics
- 05 Nov 2010 New trial record.